Two novel mutations in the CPS 1 gene of a newborn with carbamoyl phosphate synthetase 1 deficiency identified by next-generation sequencing

Carbamoyl phosphate synthetase 1 deficiency (CPS1D) is a rare autosomal recessive hereditary disease which usually presents as lethal hyperammonemia. Here we report the case of a newborn infant with lethal hyperammonemia. Blood liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis showed increased concentrations of alanine, glutamine and histidine. Urine gas chromatography-mass spectrometry (GC/MS) showed increased levels of organic acids, while uracil and whey acid were not detected. Subsequent new generation sequencing (NGS) identified two heterozygous mutations in CPS1 gene. Both of them were identified in his parents. One was c.446T>C; p.Leu149Ser, in the 4 exon of CPS1. The other was C.2023delT; p.Cys675fs, in the 17 exon of CPS1. These two novel heterozygous mutations had not been reported previously. Early diagnosis and timely intervention are very important to improve clinical outcome. The new CPS1 gene mutation broadens the spectrum of CPS1 phenotypes. NGS is a credible way in complex diseases without a specific phenotype.

[1]  F. Endo,et al.  Diagnosis and treatment of urea cycle disorder in Japan , 2014, Pediatrics international : official journal of the Japan Pediatric Society.

[2]  A. Maitra,et al.  Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development , 2011, Science Translational Medicine.

[3]  O. Lichtarge,et al.  Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations , 2011, Human mutation.

[4]  I. Pérez-Arellano,et al.  Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency. , 2010, Molecular genetics and metabolism.

[5]  D. Dressman,et al.  Heteroplasmic mitochondrial DNA mutations in normal and tumor cells , 2010, Nature.

[6]  J. Aschner,et al.  Quantitative RT-PCR comparison of the urea and nitric oxide cycle gene transcripts in adult human tissues. , 2009, Molecular genetics and metabolism.

[7]  P. Keskinen,et al.  Hereditary urea cycle diseases in Finland , 2008, Acta paediatrica.

[8]  黒川 啓二.  Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency , 2008 .

[9]  J. Häberle,et al.  Genetic approach to prenatal diagnosis in urea cycle defects , 2004, Prenatal diagnosis.

[10]  E. Zammarchi,et al.  Structural organization of the human carbamyl phosphate synthetase I gene (CPS1) and identification of two novel genetic lesions , 2003, Human mutation.

[11]  E. Christensen,et al.  Gene structure of human carbamylphosphate synthetase 1 and novel mutations in patients with neonatal onset , 2003, Human mutation.

[12]  H. Heymans,et al.  Intestinal Carbamoyl Phosphate Synthase I in Human and Rat: Expression During Development Shows Species Differences and Mosaic Expression in Duodenum of Both Species , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  S. Brusilow,et al.  Urea cycle disorders: diagnosis, pathophysiology, and therapy. , 1996, Advances in pediatrics.

[14]  M. Tuchman,et al.  Physical and linkage mapping of human carbamyl phosphate synthetase I (CPS1) and reassignment from 2p to 2q35. , 1995, Cytogenetics and cell genetics.

[15]  M. Takiguchi,et al.  Cloning and sequence of a cDNA encoding human carbamyl phosphate synthetase I: molecular analysis of hyperammonemia. , 1991, Gene.

[16]  I. Matsuda,et al.  Estimated frequency of urea cycle enzymopathies in Japan. , 1991, American journal of medical genetics.